Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with neoadjuvant chemoradiation before surgery for operable esophageal cancer
NL-OMON35643Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in esophageal cancer, esophagogastric junction cancer, sponsored by Amsterdam University Medical Center. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
panitumumab
03
Conditions
esophageal canceresophagogastric junction cancer
Beyond the preview
Go deeper on NL-OMON35643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35643.